Mike Bassett from MedPage Today - Journalist Profile

	Profile	Contacts	Recent Articles on Subject
1	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism		No PFS Benefit With Immune Checkpoint Inhibitor Rechallenge in Renal Cell Carcinoma - 3 days ago Antibody Drug-Conjugate Shows Promising Activity in Extensive-Stage SCLC - 5 days ago Doxorubicin-Trabectedin Strategy Boosts Survival in Challenging Sarcoma - 12 days ago Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers - 12 days ago Trial Questions Role of Dual Immunotherapy in First-Line NSCLC - 25 days ago Targeted First-Line Combo Approved for EGFR-Mutated Lung Cancer - 27 days ago Study: Avoid Completion ALND for Abemaciclib Eligibility in Early Breast Cancer - about 1 month ago Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies - about 2 months ago FDA Greenlights First Engineered Cell Therapy for a Solid Tumor - about 2 months ago EHR 'Nudge' Cut Low-Value Surgery Rates in Older Breast Cancer Patients - 2 months ago Immunotherapy Combo Active in Advanced PD-L1-Negative HNSCC - 2 months ago Mediterranean Diet Tied to Lower Mortality Risk in Cancer Survivors - 2 months ago Celebrity Cancers Stoking Fear? Cisplatin Shortage Ends; Setback for Anti-TIGIT - 2 months ago Most Women Can Have Successful Pregnancies After Breast Cancer Treatment - 4 months ago Blood Test for Colon Cancer Screening Secures FDA Panel's Blessing - 4 months ago HIFU Non-Inferior to Prostatectomy for Localized Prostate Cancer - 5 months ago Journey Into Virtual Reality Eases Cancer Pain - 5 months ago Francis Collins Discloses His 'Aggressive' Prostate Cancer Diagnosis - 5 months ago Novel PARP1 Inhibitor Shows Promise in Breast Cancer - 5 months ago Can Late-Stage Cancer Incidence Serve as an Endpoint for Screening Trials? - 5 months ago Most Cancer Drugs Granted Accelerated Approval Fail Confirmatory Trials - 5 months ago PSA and Biomarker Testing Plus MRI Appears to Improve Prostate Cancer Screening - 5 months ago More Bird Flu Spread; FDA to Allow Gay Men to Donate Sperm; 'Oatzempic' Trend - 5 months ago Chemotherapy/ICI Combos Falter as Second-Line Treatment for Gastric Cancer - 6 months ago Evidence Strengthens for De-Escalating Axillary Surgery in Breast Cancer - 6 months ago PD-1 Inhibitor Plus Chemotherapy Shows Promising Activity in Rare Lymphoma - 6 months ago Liquid Biopsy for CRC Screening May Not Be Ready for Prime Time - 6 months ago Rucaparib Maintenance Boosts PFS in Metastatic, Recurrent Endometrial Cancer - 6 months ago FDA Panel Endorses Imetelstat for MDS-Related Anemia - 6 months ago FDA Staff Cast Doubt on Novel Drug for MDS-Related Anemia - 6 months ago First-Line Nivolumab Plus Chemo Approved for Bladder Cancer - 6 months ago First-Line Immunotherapy Alone Sufficient for Older NSCLC Patients, Study Suggests - 6 months ago A Blenrep Comeback? Cancer Vaccine for Dogs; U.K. Snubs Enhertu - 6 months ago Novel Therapy Promising for Radiation-Induced Oral Mucositis - 7 months ago Two Pembrolizumab Trials in Head and Neck Cancer Yield Divergent Results - 7 months ago Cancer Prevention Strategies Linked to Mortality Reduction in BRCA Carriers - 7 months ago FDA Announces End to 'Forever Chemicals' in U.S. Food Packaging - 7 months ago FDA Approves Antibiotic Combination for Complicated UTIs - 7 months ago Male Fertility Problems in the Family Linked to Cancer Risk - 7 months ago Annual Breast Cancer Screening Starting at Age 40 Best, Modeling Study Says - 7 months ago FDA OKs First Cellular Therapy for Melanoma - 7 months ago Perioperative Tislelizumab Demonstrates Survival Benefit in NSCLC - 7 months ago Immunotherapy May Hold Promise for Skin Cancers After Kidney Transplant - 7 months ago New First-Line Option for Pancreatic Cancer Approved - 7 months ago Hyperbaric Oxygen Therapy Shows Some Benefit After Breast Cancer Irradiation - 7 months ago Trader Joe's Food Alert; DEA Reverses Decision; Going Maskless Is Not Free Speech - 7 months ago All-Oral Therapy Promising in Higher-Risk MDS, CMML - 7 months ago Cabozantinib Plus Atezolizumab Delays Progression in mCRPC - 8 months ago No Cervical Cancer After HPV Vax; Brain Tumor Blood Test; Weight Loss and Cancer - 8 months ago Olaparib-Abiraterone in Biomarker-Selected mCRPC Tops Each Agent Alone - 8 months ago